Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
EVMN
EVMN News & Events
-
Add to Watchlist
Trade EVMN
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
EVMN News
Aktis Oncology Launches $200 Million IPO with $100 Million Investment from Eli Lilly
Jan 09 2026
renaissancecapital
Analysts Adjust Ratings on Wealthfront and Spire Global with Price Targets
Jan 06 2026
Benzinga
Aktis Oncology Files for IPO in the U.S. Targeting $346 Million in Funding
Dec 19 2025
Newsfilter
Carnival Reports Robust Q4 Earnings, Alongside Amicus Therapeutics, Biomarin Pharmaceutical, and Other Major Stocks Rising on Friday
Dec 19 2025
Benzinga
Evommune Raises $172.5M in IPO to Advance Key Clinical Trials
Dec 11 2025
Newsfilter
Analyst Predicts $5 Billion Peak Sales for Evommune's Skin Disorder Treatment, Calling It a 'Blockbuster Commercial Opportunity'
Dec 01 2025
Benzinga
William Blair Begins Coverage of Evommune with an Outperform Rating
Dec 01 2025
Benzinga
Joby Aviation Analyst Starts Coverage with a Bearish Outlook; Check Out the Top 5 Initiations for Monday
Dec 01 2025
Benzinga
Show More News
EVMN Events
No data
EVMN Monitor News
No data
EVMN Earnings Analysis
No Data
People Also Watch
